Y-mAbs Therapeutics (NASDAQ:YMAB) Trading 2.8% Higher

Shares of Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) were up 2.8% on Tuesday . The company traded as high as $12.50 and last traded at $12.45. Approximately 32,320 shares changed hands during trading, a decline of 92% from the average daily volume of 411,775 shares. The stock had previously closed at $12.11. Analysts […]

Related Keywords

United States , ,Acadian Asset Management ,Exchange Traded Concepts ,Unisuper Management Pty Ltd ,Y Mabs Therapeutics Inc ,Principal Financial Group Inc ,Nasdaq ,Y Mabs Therapeutics ,Get Free Report ,Abs Therapeutics ,Thomas Gad ,Asset Management ,Traded Concepts ,Super Management Pty Ltd ,Principal Financial Group ,Financial Group ,Y Mabs Therapeutics Daily ,Nasdaq Ymab ,Kymab ,Medical ,Stocks ,Technicals ,